RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Mutual Recognition Agreements in the EU, Canada and Other Countries

Mutual Recognition Agreements in the EU, Canada and Other Countries

Posted 01 March 2010

Human and veterinary drugs are heavily regulated to ensure that they meet minimum requirements regarding quality and safety before being placed on the market. Historically, drug regulations were based on the same fundamental obligations of quality, safety and efficacy; however, regional differences in technical requirements have arisen over time. These differences often require time-consuming and expensive duplicate testing and inspections for international registrations.1

 

© 2022 Regulatory Affairs Professionals Society.